ProSci Incorporated
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ProSci Incorporated - overview
Established
1998
Location
-, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 1998, ProSci Incorporated is a biotechnology company that specializes in producing antibodies, proteins, and reagents for research and diagnostic applications. In February 2023, Genesee Scientific Corporation, a portfolio company of LLR Partners, acquired ProSci Incorporated. ProSci Incorporated is a biotechnology company that operates with the aim of producing antibodies, recombinant proteins, and other reagents for various research fields, particularly in the discovery of cancer biomarkers and the development of neutralizing antibodies against emerging viruses such as HIV and influenza, specializing in custom monoclonal, polyclonal, and single-domain antibody development.
Current Investors
Genesee Scientific Corporation
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare, Pharmaceuticals
Website
www.prosci-inc.com
Verticals
HealthTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
ProSci Incorporated - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | ProSci Incorporated | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.